ES2089395T3 - Utilizacion de rapamicina para tratar la diabetes. - Google Patents

Utilizacion de rapamicina para tratar la diabetes.

Info

Publication number
ES2089395T3
ES2089395T3 ES92302842T ES92302842T ES2089395T3 ES 2089395 T3 ES2089395 T3 ES 2089395T3 ES 92302842 T ES92302842 T ES 92302842T ES 92302842 T ES92302842 T ES 92302842T ES 2089395 T3 ES2089395 T3 ES 2089395T3
Authority
ES
Spain
Prior art keywords
rapamicine
treat diabetes
insulin
arresting
retarding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92302842T
Other languages
English (en)
Inventor
William Lee Baeder
Surendra Nath Sehgal
Laurel Moore Adams
Thomas Joseph Caggiano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/792,105 external-priority patent/US5321009A/en
Application filed by American Home Products Corp filed Critical American Home Products Corp
Application granted granted Critical
Publication of ES2089395T3 publication Critical patent/ES2089395T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

USO DE LA RAPAMICINA PARA EL TRATAMIENTO DE LA DIABETES. ESTA INVENCION ESTA RELACIONADA CON EL USO DE LA RAPAMICINA SOLA O EN COMBINACION CON INSULINA EN LA PREVENCION PROFILACTICAMENTE DEL INICIO, DETENIENDO EL DESARROLLO, O RETARDANDO LA PROGRESION DE LA DIABETES MELLITUS DEPENDIENTE DE LA INSULINA EN UN MAMIFERO.
ES92302842T 1991-04-03 1992-03-31 Utilizacion de rapamicina para tratar la diabetes. Expired - Lifetime ES2089395T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67970691A 1991-04-03 1991-04-03
US07/792,105 US5321009A (en) 1991-04-03 1991-11-14 Method of treating diabetes

Publications (1)

Publication Number Publication Date
ES2089395T3 true ES2089395T3 (es) 1996-10-01

Family

ID=27102296

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92302842T Expired - Lifetime ES2089395T3 (es) 1991-04-03 1992-03-31 Utilizacion de rapamicina para tratar la diabetes.

Country Status (19)

Country Link
EP (1) EP0507555B1 (es)
JP (1) JP2535119B2 (es)
AT (1) ATE139120T1 (es)
AU (1) AU652037B2 (es)
CA (1) CA2064678A1 (es)
CZ (1) CZ282733B6 (es)
DE (1) DE69211406T2 (es)
DK (1) DK0507555T3 (es)
ES (1) ES2089395T3 (es)
GR (1) GR3020316T3 (es)
HK (1) HK108797A (es)
HU (1) HUT60626A (es)
IE (1) IE74884B1 (es)
IL (1) IL101353A0 (es)
MX (1) MX9201513A (es)
NO (1) NO921279L (es)
NZ (1) NZ242190A (es)
SG (1) SG43075A1 (es)
SK (1) SK279180B6 (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378696A (en) * 1990-09-19 1995-01-03 American Home Products Corporation Rapamycin esters
US5177203A (en) * 1992-03-05 1993-01-05 American Home Products Corporation Rapamycin 42-sulfonates and 42-(N-carboalkoxy) sulfamates useful as immunosuppressive agents
US5256790A (en) * 1992-08-13 1993-10-26 American Home Products Corporation 27-hydroxyrapamycin and derivatives thereof
CA2106034A1 (en) * 1992-09-24 1994-03-25 Ralph J. Russo 21-norrapamycin
US5302584A (en) * 1992-10-13 1994-04-12 American Home Products Corporation Carbamates of rapamycin
US5480989A (en) * 1992-10-13 1996-01-02 American Home Products Corporation Carbamates of rapamycin
US5480988A (en) * 1992-10-13 1996-01-02 American Home Products Corporation Carbamates of rapamycin
US5489680A (en) * 1992-10-13 1996-02-06 American Home Products Corporation Carbamates of rapamycin
US5434260A (en) * 1992-10-13 1995-07-18 American Home Products Corporation Carbamates of rapamycin
US5349060A (en) * 1993-01-07 1994-09-20 American Home Products Corporation Rapamycin 31-ester with N,N-dimethylglycine derivatives useful as immunosuppressive agents
US5252579A (en) * 1993-02-16 1993-10-12 American Home Products Corporation Macrocyclic immunomodulators
US7279561B1 (en) 1993-04-23 2007-10-09 Wyeth Anti-rapamycin monoclonal antibodies
EP1181938B1 (en) 1993-04-23 2007-11-14 Wyeth Rapamycin conjugates and antibodies
US5504091A (en) * 1993-04-23 1996-04-02 American Home Products Corporation Biotin esters of rapamycin
US5387680A (en) * 1993-08-10 1995-02-07 American Home Products Corporation C-22 ring stabilized rapamycin derivatives
US5373014A (en) * 1993-10-08 1994-12-13 American Home Products Corporation Rapamycin oximes
US5391730A (en) * 1993-10-08 1995-02-21 American Home Products Corporation Phosphorylcarbamates of rapamycin and oxime derivatives thereof
US5378836A (en) * 1993-10-08 1995-01-03 American Home Products Corporation Rapamycin oximes and hydrazones
US5385908A (en) * 1993-11-22 1995-01-31 American Home Products Corporation Hindered esters of rapamycin
US5385909A (en) * 1993-11-22 1995-01-31 American Home Products Corporation Heterocyclic esters of rapamycin
US5385910A (en) * 1993-11-22 1995-01-31 American Home Products Corporation Gem-distributed esters of rapamycin
US5389639A (en) * 1993-12-29 1995-02-14 American Home Products Company Amino alkanoic esters of rapamycin
US5525610A (en) * 1994-03-31 1996-06-11 American Home Products Corporation 42-Epi-rapamycin and pharmaceutical compositions thereof
US5362718A (en) 1994-04-18 1994-11-08 American Home Products Corporation Rapamycin hydroxyesters
US5496831A (en) * 1994-05-13 1996-03-05 The General Hospital Corporation Inhibition of insulin-induced adiposis
US5463048A (en) * 1994-06-14 1995-10-31 American Home Products Corporation Rapamycin amidino carbamates
US5491231A (en) * 1994-11-28 1996-02-13 American Home Products Corporation Hindered N-oxide esters of rapamycin
US5563145A (en) * 1994-12-07 1996-10-08 American Home Products Corporation Rapamycin 42-oximes and hydroxylamines
US5561138A (en) * 1994-12-13 1996-10-01 American Home Products Corporation Method of treating anemia
US5496832A (en) * 1995-03-09 1996-03-05 American Home Products Corporation Method of treating cardiac inflammatory disease
FR2736550B1 (fr) 1995-07-14 1998-07-24 Sandoz Sa Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule
TW427904B (en) * 1995-12-07 2001-04-01 American Home Prod Neuroprotective agents
US5780462A (en) * 1995-12-27 1998-07-14 American Home Products Corporation Water soluble rapamycin esters
US5922730A (en) * 1996-09-09 1999-07-13 American Home Products Corporation Alkylated rapamycin derivatives
US6015809A (en) * 1998-08-17 2000-01-18 American Home Products Corporation Photocyclized rapamycin
MXPA03002278A (es) * 2000-09-14 2004-12-03 Beth Israel Hospital Modulacion de respuestas de la celula t mediadas por il-2 e il-15.
CA2486584A1 (en) 2002-06-07 2003-12-18 Waratah Pharmaceuticals, Inc. Compositions and methods for treating diabetes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5100899A (en) * 1989-06-06 1992-03-31 Roy Calne Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof
US5023263A (en) * 1990-08-09 1991-06-11 American Home Products Corporation 42-oxorapamycin

Also Published As

Publication number Publication date
EP0507555A1 (en) 1992-10-07
CZ97292A3 (en) 1993-09-15
ATE139120T1 (de) 1996-06-15
EP0507555B1 (en) 1996-06-12
DE69211406D1 (de) 1996-07-18
JP2535119B2 (ja) 1996-09-18
NO921279D0 (no) 1992-04-02
DE69211406T2 (de) 1996-11-28
DK0507555T3 (da) 1996-07-01
SK279180B6 (sk) 1998-07-08
AU1395792A (en) 1992-10-08
HUT60626A (en) 1992-10-28
NZ242190A (en) 1997-06-24
CZ282733B6 (cs) 1997-09-17
IE74884B1 (en) 1997-08-13
HU9201113D0 (en) 1992-06-29
IE921055A1 (en) 1992-10-07
CA2064678A1 (en) 1992-10-04
SK97292A3 (en) 1994-11-09
JPH0597688A (ja) 1993-04-20
HK108797A (en) 1997-08-22
GR3020316T3 (en) 1996-09-30
AU652037B2 (en) 1994-08-11
IL101353A0 (en) 1992-11-15
NO921279L (no) 1992-10-05
SG43075A1 (en) 1997-10-17
MX9201513A (es) 1993-04-01

Similar Documents

Publication Publication Date Title
AU652037B2 (en) Use of rapamycin for treating diabetes
NO164410C (no) Drivanordning med laasemekanisme for heisdoer.
DE3872953D1 (de) Riemenspannvorrichtung mit bremsbanddaempfung mit federsteuerung.
NO902840D0 (no) Middel for transdermal applikasjon som inneholder gestoden
NO891013L (no) Feilsikker frigjoerende aktiveringsmekanisme.
MX9201493A (es) Jeringa no reutilizable con indicador de seguridad.
NO904354D0 (no) Sikkerhetsventil.
DE68903571D1 (de) Sicherheitssitz fuer kinder.
DE3863737D1 (de) Mechanismus mit steuerbarer daempfungsrate.
DE68911262D1 (de) Mit Nylon modifizierte Kautschukmischung.
DE3875272D1 (de) Mit hydroxy-benzimidazoloxiden modifizierte kautschukmischungen.
DE68903457D1 (de) Rueckschlagventil.
DE3881861D1 (de) Bahnspannungsvorrichtung.
ES2131122T3 (es) Uso de il-10 para prevenir la diabetes mellitus dependiente de insulina.
MX9204633A (es) Cojinete de hule con amortiguamiento hidraulico.
DE68902072D1 (de) Gummiraupenkette.
MX9205874A (es) Encendedor de bolsillo dotado de mecanismo de seguridad.
DK461087A (da) Tallerken beregnet til handicappede, isaer personer med reduceret haandfunktion.
DE68914807D1 (de) Kautschukrolle.
IT1236763B (it) Rullo pressore o tenditore.
NO912109L (no) Anti-mikrobielt middel.
DE59105620D1 (de) Sicherheitsventil.
NO912700D0 (no) Trekantdrager.
KR920006218U (ko) 안전페달 부착기구
ES1021033Y (es) Contrapeso adaptable para tractores.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 507555

Country of ref document: ES

FG2A Definitive protection

Ref document number: 507555

Country of ref document: ES